Taris Biomedical Llc Headquarters
Looking for information about Taris Biomedical Llc Headquarters? The links below have collected all the necessary data.
TARIS Biomedical LLC - Company Profile and News ...
- https://www.bloomberg.com/profile/company/8247280Z:US
- TARIS Biomedical, Inc. operates as a pharmaceutical company. The Company develops therapeutics to provide controlled-release of drugs directly into tissues to treat bladder diseases.Leader: Diane M. Marcou CPA
TARIS Biomedical - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/taris-biomedical
- Legal Name TARIS BIOMEDICAL LLC. Company Type For Profit. Contact Email [email protected]. Phone Number 781-676-7750. TARIS Biomedical a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products. The TARIS core technology and development ...Founded: 2008
TARIS Biomedical Company Profile - Office Locations ...
- https://craft.co/taris-biomedical
- Dec 20, 2019 · TARIS Biomedical has 16 employees at their 1 location and $89.19 m in total funding,. See insights on TARIS Biomedical including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.Employees: 16
TARIS Biomedical - Overview, News & Competitors ZoomInfo.com
- https://www.zoominfo.com/c/taris-biomedical-llc/351825808
- Johnson & Johnson announced today the acquisition of TARIS Biomedical LLC (TARIS), a privately-owned biotechnology company specializing in the development of a novel drug delivery technology for the treatment of bladder diseases including cancer. The company's lead clinical-stage product, TAR-200, uses the proprietary TARIS System, which ...Employees: 41
Taris Biomedical (US) Company Profile: Acquisition ...
- https://pitchbook.com/profiles/company/51604-66
- Apr 02, 2013 · Taris Biomedical (US) General Information Description. Developer of targeted new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's system is designed to continuously release drugs in the bladder over weeks to months and is deployed and retrieved using minimally-invasive, in-office procedures, enabling drug release to be tailored to match …
TARIS Biomedical Flagship Pioneering
- https://www.flagshippioneering.com/companies/taris-biomedical
- TARIS Biomedical. TARIS Biomedical® was founded in 2008 in response to a long-standing clinical need for a convenient, safe, and effective way to treat bladder disease locally. Encouraged by the effectiveness of local bladder instillations but frustrated by the need for frequent repeated dosing due to normal bladder emptying, urologists ...
TARIS Biomedical LLC careers complete history JobSearcher
- https://jobsearcher.com/c/TARIS%20Biomedical%20LLC
- Search all of TARIS Biomedical LLC's current and previously listed jobs and positions. Reach out to TARIS Biomedical LLC directly regarding career opportunities. ... Headquarters: Lexington, MA Patients can focus on living. With TARIS' approach, patients can spend their time enjoying life, not managing disease. OUR APPROACH ...
Johnson & Johnson Acquires TARIS Biomedical with Focus on ...
- https://www.prnewswire.com/news-releases/johnson--johnson-acquires-taris-biomedical-with-focus-on-transforming-the-treatment-of-bladder-cancer-300978469.html
- Dec 20, 2019 · NEW BRUNSWICK, N.J., Dec. 20, 2019 /PRNewswire/ -- Johnson & Johnson announced today the acquisition of TARIS Biomedical LLC (TARIS), a privately-owned biotechnology company specializing in the ...Estimated Reading Time: 8 mins
Johnson & Johnson Acquires TARIS Biomedical with Focus on ...
- https://www.biospace.com/article/releases/johnson-and-amp-johnson-acquires-taris-biomedical-with-focus-on-transforming-the-treatment-of-bladder-cancer/
- Dec 20, 2019 · NEW BRUNSWICK, N.J., Dec. 20, 2019 /PRNewswire/ -- Johnson & Johnson announced today the acquisition of TARIS Biomedical LLC (TARIS), a privately-owned biotechnology company specializing in the development of a novel drug delivery technology for the treatment of bladder diseases including cancer. The company's lead clinical-stage product, TAR-200, uses the proprietary TARIS …
Johnson & Johnson Acquires TARIS Biomedical with Focus on ...
- https://pipelinereview.com/index.php/2019122173350/More-News/Johnson-Johnson-Acquires-TARIS-Biomedical-with-Focus-on-Transforming-the-Treatment-of-Bladder-Cancer.html
- Dec 21, 2019 · Novel Drug Delivery Technology Strengthens Targeted Oncologic Therapy Approach. NEW BRUNSWICK, NJ, USA I December 20, 2019 I Johnson & Johnson announced today the acquisition of TARIS Biomedical LLC (TARIS), a privately-owned biotechnology company specializing in the development of a novel drug delivery technology for the treatment of bladder diseases including …
Have you found Taris Biomedical Llc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.